In this podcast, Schizophrenia Section Editor Leslie Citrome, MD, MPH, reviews recent developments and possible upcoming advances in the treatment of schizophrenia, including new mechanisms of action and methods of delivering medicine.
Isabela Pina, MD, discusses her study that found positive psychology interventions may be a beneficial resource for patients on the schizophrenia spectrum, with possible impacts on well-being and symptom reduction.
In this Q&A, Katlyn Nemani, MD, of the New York University School of Medicine, discusses her study which found a schizophrenia spectrum diagnosis was associated with increased mortality risk in patients with COVID-19.
Researcher Benjamin Perry, MRCPsych, of the University of Cambridge, England, discusses a study published in JAMA Psychiatry which linked physical conditions early in life with later psychiatric disorders.
According to a recent study, at age 66, what percentage of patients with schizophrenia had a dementia diagnosis, compared with 1.3% of patients without serious mental illness? Take our short quiz to find out.
In this podcast, Jonathan Meyer, MD, discusses the role of D2 antagonism in schizophrenia treatment, lessons learned about schizophrenia treatment from clozapine, and emerging treatments for schizophrenia and their therapeutic targets.